Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

被引：0
|
作者：
Sakin, Yusuf Serdar [1 ]
Polat, Zulfikar [1 ]
Demirci, Hakan [1 ]
Kekilli, Murat [2 ]
Uygun, Ahmet [1 ]
Bagci, Sait [1 ]
机构：
[1] Gulhane Mil Med Acad, Dept Gastroenterol, Ankara, Turkey
[2] Hitit Univ, Corum, Turkey
来源：
HEPATOLOGY RESEARCH | 2014年 / 44卷 / 09期
关键词：
D O I：
10.1111/hepr.12278
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [1] Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
    Fukuda, Kazuto
    Imai, Yasuharu
    Hiramatsu, Naoki
    Irishio, Keiko
    Igura, Takumi
    Sawai, Yoshiyuki
    Kogita, Sachiyo
    Makino, Yuki
    Mizumoto, Rui
    Matsumoto, Yasushi
    Nakahara, Masanori
    Zushi, Sinichiro
    Kajiwara, Nobuyuki
    Oze, Tsugiko
    Kawata, Sumio
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY RESEARCH, 2014, 44 (12) : 1165 - 1171
  • [2] Eruptions in Patients with chronic hepatitis C receiving combination therapy with Telaprevir, Peginterferon and Ribavirin
    Eleftheriadis, V
    Stadler, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 869 - 869
  • [3] Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
    Soza, Alejandro
    Labbe, Pilar
    Arrese, Marco
    Riquelme, Arnoldo
    Barrera, Francisco
    Benitez, Carlos
    Huete, Alvaro
    Elvira Balcells, M.
    Labarca, Jaime
    ANNALS OF HEPATOLOGY, 2015, 14 (01) : 132 - 136
  • [4] Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 157 - 159
  • [5] REDUCED RENAL FUNCTION IS ASSOCIATED WITH ANEMIA DURING TREATMENT WITH PEGINTERFERON/RIBAVIRIN IN ELDERLY CHRONIC HEPATITIS C PATIENTS
    Ceriani, R.
    Andreoletti, M.
    Borroni, G.
    Bortoli, A.
    Casiraghi, M.
    Cazzaniga, M.
    Guerzoni, P.
    Mandelli, G.
    Omazzi, B.
    Pich, M. G.
    Prada, A.
    Terreni, N.
    Spinzi, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S162 - S162
  • [6] ITPA GENE VARIANTS AND ANEMIA DURING TELAPREVIR/PEGINTERFERON/RIBAVIRIN COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
    Tuefferd, M.
    Palescandolo, E.
    Vijgen, L.
    Colombo, M.
    Roberts, S.
    Wedemeyer, H.
    Zeuzem, S.
    De Meyer, S.
    Demasi, R.
    Witek, J.
    Lonjon-Domanec, I.
    Aerssens, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S490 - S490
  • [7] ADHERENCE RATES FOR PEGINTERFERON plus RIBAVIRIN COMPARED WITH TELAPREVIR plus PEGINTERFERON plus RIBAVIRIN IN MEDICAID AND COMMERCIAL PATIENTS TREATED FOR CHRONIC HEPATITIS C
    Samp, J. C.
    Walker, D.
    Manthena, S.
    Juday, T.
    VALUE IN HEALTH, 2014, 17 (07) : A368 - A368
  • [8] Results of treatment with peginterferon plus ribavirin in patients with chronic hepatitis C
    Pizarro, Carolina
    Venegas, Mauricio
    Hola, Karen
    Smok, Gladys
    Brahm, Javier
    REVISTA MEDICA DE CHILE, 2011, 139 (06) : 704 - 709
  • [9] Peginterferon and ribavirin for hepatitis C - Reply
    Hoofnagle, Jay H.
    Seeff, Leonard B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (12): : 1271 - 1271
  • [10] SHORTENED PEGINTERFERON AND RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C
    Hartwell, Debbie
    Jones, Jeremy
    Baxter, Louise
    Shepherd, Jonathan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (04) : 398 - 406
12345